DGAP-DD: Heidelberg Pharma AG english

EQS Group · Uhr


Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

22.02.2022 / 17:45
The issuer is solely responsible for the content of this announcement.

1. Details of the person discharging managerial responsibilities / person closely associated

a) Name
Name and legal form: MH-LT-Investments GmbH

2. Reason for the notification

a) Position / status
Person closely associated with:
Title: Dr.
First name: Mathias
Last name(s): Hothum
Position: Member of the administrative or supervisory body

b) Initial notification

3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a) Name
Heidelberg Pharma AG

b) LEI
391200E09XYBYITR1W32 

4. Details of the transaction(s)

a) Description of the financial instrument, type of instrument, identification code
Type: Share
ISIN: DE000A11QVV0

b) Nature of the transaction
Acquisition of 453,761 shares of the issuer as compensation in connection with the withdrawal from the dievini Hopp BioTech holding GmbH & Co. KG

c) Price(s) and volume(s)
Price(s) Volume(s)
0.0000 EUR 0.0000 EUR

d) Aggregated information
Price Aggregated volume
0.0000 EUR 0.0000 EUR

e) Date of the transaction
17/02/2022; UTC+1

f) Place of the transaction
Outside a trading venue


22.02.2022 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de

Language: English
Company: Heidelberg Pharma AG
Gregor-Mendel-Str. 22
68526 Ladenburg
Germany
Internet: www.heidelberg-pharma.com

 
End of News DGAP News Service

72863  22.02.2022 

fncls.ssp?fn=show_t_gif&application_id=1285909&application_name=news&site_id=onvista

Das könnte dich auch interessieren

Meistgelesene Artikel